ETF Building Blocks Content Hub Don’t Miss Out on Rampant Biotech Mergers with the SBIO ETF By Tom LydonJanuary 13, 2021
Innovative ETFs Content Hub Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 By Max ChenDecember 31, 2020
Active ETF Content Hub Keep Your Quality’s Momentum: Introducing the Virtus JOET ETF By Tom LydonNovember 19, 2020
ETF Building Blocks Content Hub How Increased FDA Activity Can Benefit ETFs in Your Portfolio By Tom LydonNovember 19, 2020
New ETFs Virtus ETF Launch Shorts Exposure to Large/Mid-Cap U.S. Equities By Brenton GarenJune 28, 2017
